PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAG9. A total of 18 filers reported holding PDL BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $15,504,000 | +7.9% | 16,117,000 | +18.4% | 0.21% | -4.1% |
| Q2 2019 | $14,364,000 | -17.2% | 13,617,000 | -9.9% | 0.22% | -44.8% |
| Q1 2019 | $17,351,000 | +25.6% | 15,117,000 | +11.0% | 0.40% | +2.6% |
| Q4 2018 | $13,814,000 | -47.5% | 13,617,000 | -48.8% | 0.39% | -51.6% |
| Q3 2018 | $26,292,000 | +2.5% | 26,617,000 | -4.5% | 0.80% | +1.1% |
| Q2 2018 | $25,654,000 | -9.8% | 27,867,000 | 0.0% | 0.79% | +17.2% |
| Q1 2018 | $28,432,000 | +5.0% | 27,867,000 | 0.0% | 0.67% | -15.8% |
| Q4 2017 | $27,090,000 | +7.5% | 27,867,000 | +20.1% | 0.80% | -10.5% |
| Q3 2017 | $25,190,000 | +209.0% | 23,210,000 | +157.9% | 0.89% | +159.9% |
| Q2 2017 | $8,152,000 | +85.7% | 9,000,000 | +80.0% | 0.34% | +111.0% |
| Q1 2017 | $4,391,000 | +35.0% | 5,000,000 | +25.0% | 0.16% | +28.3% |
| Q4 2016 | $3,253,000 | – | 4,000,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|